Opendata, web and dolomites

TETCOLON SIGNED

Dissecting the role of the epigenetic regulator TET2 in colorectal cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TETCOLON project word cloud

Explore the words cloud of the TETCOLON project. It provides you a very rough idea of what is the project "TETCOLON" about.

techniques    transcriptome    methylation    epigenome    perturbed    methylated    cells    ten    translational    genomic    normal    bioinformatics    eleven    seq    virtually    molecular    stability    load    pathogenesis    levels    bystander    epigenetics    3d    pathological    colonic    supporting    5mcs    crc    significance    deficient    preliminary    survival    human    cancer    dioxygenases    predictive    methylome    therapies    knockdown    aberrantly    contributes    disciplinary    suppression    rna    culture    event    carcinogenesis    oxidized    instability    tumor    suggests    oncogenic    causal    colorectal    genetic    vulnerabilities    contain    ultimately    epi    expression    genes    predicts    helping    cell    mediated    revealed    active    dna    family    accumulation    combining    induces    elucidate    epigenomic    biomarker    reprogramming    driver    edge    demethylation    mutational    link    translocation    tet2    clinico    mouse    5mc    crcs    oxidize    5hmc    tet1    clear    mechanism    tet    defects    patterns    therapeutic    basic    protein    correlations    tissue    innovative    cutting    methylcytosine    biology    probe    indicates    hydroxymethylcytosine    epithelial    epigenetic    mrna    deficiency   

Project "TETCOLON" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI PAVIA 

Organization address
address: STRADA NUOVA 65
city: PAVIA
postcode: 27100
website: www.unipv.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 183˙473 €
 EC max contribution 183˙473 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-RI
 Starting year 2020
 Duration (year-month-day) from 2020-09-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI PAVIA IT (PAVIA) coordinator 183˙473.00

Map

 Project objective

Colorectal cancer (CRC) results from the accumulation of genetic and epigenetic changes in colonic epithelial cells. Epigenome studies revealed that virtually all CRCs contain aberrantly methylated genes and perturbed methylation patterns. Ten-Eleven Translocation (TET) protein family dioxygenases oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and further to other oxidized 5mCs, supporting active DNA demethylation and helping maintain epigenomic stability. Loss of TET1 is an oncogenic driver in some CRCs. My preliminary analysis indicates that human CRCs have low TET2 mRNA levels compared to normal colorectal tissue, and suggests that low TET2 expression predicts increased mutational load and reduced overall survival. However, whether TET2 deficiency contributes to CRC pathogenesis, or represents a bystander event, remains to be established. In this proposal, I will elucidate the role of TET2 in CRC pathogenesis by testing whether TET2 knockdown induces methylome and transcriptome reprogramming, ultimately promoting (epi)genomic instability and tumor growth. I will also investigate correlations between TET2 defects and molecular/clinico-pathological parameters, and probe TET2 expression as predictive biomarker of response to CRC therapies. With these aims, I will use a multi-disciplinary approach, combining cell biology, cancer epigenetics, bioinformatics, human and mouse studies with cutting-edge techniques such as 3D cell culture and RNA-seq. This study should establish a clear causal link between TET2 loss and CRC pathogenesis, providing new insight into the mechanism of TET2-mediated tumor suppression and leading to the development of innovative therapies that exploit vulnerabilities of TET2-deficient CRC cells. Overall, this project has both basic and translational significance, and the potential to advance our understanding of CRC carcinogenesis and therapeutic response.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TETCOLON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TETCOLON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

GENI (2019)

Gender, emotions and national identities: a new perspective on the abortion debates in Italy (1971-1981).

Read More  

ICL CHROM (2020)

DNA interstrand crosslink repair and chromatin remodelling

Read More  

TheaTheor (2018)

Theorizing the Production of 'Comedia Nueva': The Process of Play Configuration in Spanish Golden Age Theater

Read More